Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil 23 mg SR vs 10 mg IR in Moderate to Severe Alzheimer's Disease
NCT00478205Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Started Jun 2007; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00478205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00478205.